Synchroneuron Receives $6,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f438e6c8-f3fb-47f6-9e6b-e034ebbd6db1&Preview=1 -
Date
2/7/2012 -
Company Name
Synchroneuron -
Mailing Address
Undisclosed Waltham, MA 02451 -
Company Description
Synchroneuron Inc., a Waltham, Mass.-based biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$6,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The company did not state what it intended to do with the funds, but it did note that it expects to start Phase 1 clinical trials this year for a new drug therapy to treat Tardive dyskinesia. -
M&A Terms
-
Venture Investor
Morningside Group
